Findings indicate that altering glucose metabolism in T cells boosts their therapeutic potential against melanoma, paving the way for improved immunotherapies.

At the core of this cycle are T cells, the immune system's primary cancer-fighting cells. But T cells do not work alone; they rely on activation from other immune cells, particularly antigen ...

Researchers found that bioengineered CAR-T cells when mixed with other immune cells can "donate" proteins, suggesting ...

CAR T cell therapy is one of the most promising new cancer treatments to emerge in recent years. It involves removing a patient's own immune T cells and engineering them to recognize specific targets ...

Cells get nutrients from their environment ... However, photosynthesis doesn't just drive the carbon cycle — it also creates the oxygen necessary for respiring organisms. Interestingly, although ...

Cell cycle events are controlled tightly by several kinase families including CDKs, Plks, and Aurora kinases. What is interesting about these kinases is that they don't always act alone.

Its design mirrors the previous Phase III FLASH study, which consisted of three six-week treatment cycles, with the assessment of primary efficacy at the end of the first six-week cycle.